Integra LifeSciences Holdings Corporation (IART) vs Replimune Group, Inc. (REPL)
A side-by-side comparison of Integra LifeSciences Holdings Corporation and Replimune Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IART
Integra LifeSciences Holdings Corporation
$13.27HealthcareDelayed quote: Oct 6, 2026, 1:40 PM EDT
REPL
Replimune Group, Inc.
$13.07HealthcareDelayed quote: Oct 6, 2026, 1:40 PM EDT
Total return — IART vs REPL
growth of $100 · dividends reinvested · last 8yIART -79.0% (-17.7%/yr)REPL -13.3% (-1.8%/yr)REPL compounded faster over this window
IART REPL
IART vs REPL: by the numbers
- •REPL is the larger company ($1.10B vs $1.03B market cap).
- •Both run net losses; REPL's is the smaller (0.00% vs -0.44% net margin).
Metrics side by side
Valuation
| Metric | IART | REPL |
|---|---|---|
| Forward P/E | 5.44 | N/A |
| P/S ratio | 0.63 | N/A |
| P/B ratio | 0.98 | 10.40 |
| EV / EBITDA | 3.53 | N/A |
Profitability
| Metric | IART | REPL |
|---|---|---|
| Gross margin | 53.74% | 0.00% |
| Operating margin | 4.18% | 0.00% |
| Net margin | -0.44% | 0.00% |
| ROE | -0.69% | -281.14% |
| ROIC | 20.01% | -139.11% |
Growth (annualized)
| Metric | IART | REPL |
|---|---|---|
| Revenue CAGR (5Y) | 1.77% | N/A |
| Total return CAGR (5Y) | -28.16% | -15.17% |
Frequently asked
- How have IART and REPL total returns compared?
- Over the past 5 years, IART delivered -28.16% and REPL delivered -15.17% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Integra LifeSciences ROEReplimune ROEIntegra LifeSciences operating marginReplimune operating marginIntegra LifeSciences revenue growthReplimune revenue growthIntegra LifeSciences free cash flowReplimune free cash flow
Integra LifeSciences & Replimune appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.